Clinical trial · Observational
Registrar Performances in MIDP
Registrar Performance in Laparoscopic Distal Pancreatectomy and Its Effect on Postoperative Outcomes
NCT04429074CI-TRIAL-00045518completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to determine whether registrar involvement in minimally invasive distal pancreatectomy (MIDP) was associated with adverse outcomes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Minimally Invasive Distal Pancreatectomy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Minimally invasive distal pancreatectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Group 1 (Registrar)
- description
- Group 1 (Registrar): Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology operated on by a registrar (young specialist surgeon)
- interventionNames
- Procedure: Minimally invasive distal pancreatectomy
- label
- Group 2 (Consultant)
- description
- Group 2 (Consultant): Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology operated on by a consultant (expert)
- interventionNames
- Procedure: Minimally invasive distal pancreatectomy
Primary outcomes (1)
- measure
- open conversion rate
- timeFrame
- 1 day
- description
- Necessity to swith from minimally invasive approach to open approach during laparoscopy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion criteria: \- Patients who underwent minimally invasive distale pancreatectomy for benign or borderline pathology between 2009-2020 Exclusion criteria: * open distal pancreatectomy * minimally invasive distal pancreatectomy for pancreatic cancer * 20 first consecutive patients operated on by the consultant (learning curve)
References
Publications (0)
Data not yet available
No reference posted for this study.